Intraarterial thrombolysis in vertebrobasilar occlusion

American Journal of Neuroradiology

Volumn 17, Issue 2, 1996, Pages 255-262

  Becker, Kyra J ^a,b   Monsein, Lee H ^a   Ulatowski, John ^a   Mirski, Marek ^a   Williams, Michael ^a   Hanley, Daniel F ^a  

^a JOHNS HOPKINS HOSPITAL   (United States)

^b NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

Author keywords

Arteries, basilar; Arteries, stenosis and occlusion; Efficacy studies; Thrombolysis

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; HEPARIN; HYPERTENSIVE AGENT; UROKINASE;

ADULT; AGED; ARTICLE; BRAIN ANGIOGRAPHY; BRAIN HEMORRHAGE; CLINICAL ARTICLE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FIBRINOLYTIC THERAPY; HUMAN; INTRAARTERIAL DRUG ADMINISTRATION; MALE; MORTALITY; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; TREATMENT OUTCOME; VERTEBRAL ARTERY STENOSIS;

AGED; FEMALE; HUMANS; INFUSIONS, INTRA-ARTERIAL; INTRACRANIAL EMBOLISM AND THROMBOSIS; MALE; MIDDLE AGED; SURVIVAL RATE; THROMBOLYTIC THERAPY; TREATMENT OUTCOME; URINARY PLASMINOGEN ACTIVATOR; VERTEBROBASILAR INSUFFICIENCY;

EID: 0030047748     PISSN: 01956108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Archer CR, Horenstein S. Basilar artery occlusion: clinical and radiographic correlation. Stroke 1977;8:383-391
2. Brückmann H, Ferbert A, del Zoppo GJ, Hacke W, Zeumer H. Acute basilar thrombosis: angiologic-clinical comparison and therapeutic implications. Acta Radiol 1987;369(suppl):38-42
3. Hacke W, Zeumer H, Ferbert A, Brückmann H, del Zoppo GJ. Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar disease. Stroke 1988;19:1216-1222
4. McDowell FH, Potes J, Groch S. The natural history of internal carotid and vertebral-basilar artery occlusion. Neurology 1961; 11(part 2):153-157
5. Nadeau S, Jordan J, Mishra S. Clinical presentation as a guide to early prognosis in vertebrobasilar stroke. Stroke 1992;23:165-170
6. Moufarru NA, Little JR, Furlan AJ, Leatherman JR, Williams GW. Basilar and distal vertebral artery stenosis: long-term follow-up. Stroke 1986;17:938-941
7. Zeumer H. Local thrombolysis in the management of acute cerebral ischemia. Arzneimttelforshung 1993;41:352-354
8. Reul J, Thron A, Mull M. Local intra-arterial fibrinolysis of acute basilar artery occlusion with tissue plasminogen activator: is the use of a microcatheter necessary? Neuroradiology 1991;33:S167
9. Zeumer H, Freitag H-J, Zanella F, Thie A, Arning C. Local intra-arterial fibrinolytic therapy in patients with acute stroke: urokinase versus recombinant tissue plasminogen activator (r-tPA). Neuroradiology 1993;35:159-162
10. Nenci GG, Gresele P, Taramelli M, Agnelli G, Signorini E. Thrombolytic therapy for thromboembolism of the vertebrobasilar artery. Angiology 1983;34:561-571
11. Wildemann B, Hutschenreuter M, Krieger D, Hacke W, von Kummer R. Infusion of recombinant tissue plasminogen activator for treatment of basilar artery occlusion. Stroke 1990;21:1513-1514
12. Hederscheé D, Limburg M, Hijdra A, Koster PA. Recombinant tissue plasminogen activator in two patients with basilar artery occlusion. J Neurol Neurosurg Psychiatry 1991;54:71-73
13. Bockenheimer St, Reinhuber F, Mohs C. Intraaretielle thrombolyse himversorgender Gefäβe. Radiologe 1991;31:210-215
14. Overgaard K, Sperling B, Boysen G, et al. Thrombolytic therapy in acute ischemic stroke: A Danish pilot study. Stroke 1993;24: 1439-1446
15. Brott TG, Haley EC, Levy DE, et al. Urgent therapy for stroke, I: pilot study of tissue plasminogen activator administered within 90 minutes. Stroke 1992;23:632-640
16. Haley EC, Levy DE, Brott TG, et al Urgent therapy for stroke, II: pilot study of tissue plasminogen activator administered 91-180 minutes from onset. Stroke 1992;23:641-645
17. Mori E, Yoneda Y, Tabuchi M, et al. Intravenous recombinant tissue plasminogen activator in acute carotid artery territory stroke. Neurology 1992;42:976-982
18. Fisher CM, Gore I, Okabe M, White PD. Atherosclerosis of the carotid and vertebral arteries-extracranial and intracranial. J Neuropathol Exp Neurol 1965;24:455-476
19. Kubik CS, Adams RA. Occlusion of the basilar artery: a clinical and pathologic study. Brain 1946;69:6-121
20. Castaigne P, Lhermitte F, Gaultier JC, et al. Arterial occlusions in the vertebrobasilar system: a study of 44 patients with postmortem data. Brain 1973;96:133-154
21. Thompson JR, Simmons CR, Hasso AM, Hinshaw DB Jr. Occlusion of the intradural vertebrobasilar artery. Neuroradiology 1978; 14:219-229
22. Fields WS, Ratinov G, Wiebel J, Campos RJ. Survival following basilar artery occlusion. Arch Neurol 1966;15:463-471
23. Hallenbeck JM, Dutka AJ, Tanishtma T, et al. Polymorphonuclear leukocyte accumulation in brain regions with low blood flow during the early post ischemic period. Stroke 1986;17:246-253
24. Grøgaard B, Shürer L, Gerdin B, Arfors KE. Delayed hypoperfusion after incomplete forebrain ischemia in the rat: the role of polymorphonuclear leukocytes. J Cereb Blood Flow Metab 1989; 9:500-505
25. del Zoppo GJ. Schmid-Schönbein GW, Mori E, Copeland BR, Chang C-M. Polymorphonuclear leukocytes occlude capillaries following middle cerebral artery occlusion and reperfusion in baboons Stroke 1991:22:1276-1283
26. Mori E, del Zoppo GJ, Chambers JD, Copeland BR, Arfors KE. Inhibition of polymorphonuclear leukocyte adherence suppresses no-reflow after focal cerebral ischemia in baboons. Stroke 1992; 23:712-718
27. Barone FC, Schmidt DB, Hillegass Price WJ, et al. Reperfusion increases neutrophils and leukotriene B4 receptor binding in rat focal ischemia. Stroke 1992;23:1337-1348
28. Niu X-F, Smith CW, Kubes P. Intracellular oxidative stress induced by nitric oxide synthesis inhibition increases endothelial cell adhesion to neutrophils. Circ Res 1994;74:1122-1140
29. Simonson SG, Zhang J, Canada AT Jr, Su Y-F, Benveniste H, Piantadosi CA. Hydrogen peroxide production by monoamine oxidase during ischemia-reperfusion in the rat brain. J Cereb Blood Flow Metab 1993;13:125-134
30. Rehncrona S, Folbergrova J, Smith DS, Siesjö BK. Influence of complete and pronounced incomplete cerebral ischemia and subsequent recirculation on cortical concentrations of oxidized and reduced glutathione in the rat. J Neurochem 1980;34:477-486
31. Siesjö BK, Agardh C-D, Bengtsson F. Free radicals and brain damage. Cerebrovasc Brain Metab Rev 1989;1:165-211
32. Gash AK, Spann JF, Sherry S, et al. Factors influencing reocclusion after coronary thrombolysis for acute myocardial infarction. Am J Cardiol 1986;57:175-177
33. Hsia J, Hamilton WP, Kleiman N, Roberts T, Chaitman BR, Ross AM for the heparin-aspirin reperfusion trial (HART) investigators. A comparison between heparin and low dose aspirin as adjunctive therapy with tissue plasminogen activator for acute myocardial infarction. N Engl J Med 1990;323:1433-1437
34. Roux S, Christeller S, Ludin E. Effects of aspirin on coronary reocclusion and recurrent ischemia after thrombolysis: a meta-analysis. J Am Coll Cardiol 1992;19:671-677
35. Bleich SD, Nichols TC, Schumacher RR, Cooke DH, Tate DA, Teichman SL. Effect of heparin on coronary arterial patency after thrombolysis with tissue plasminogen activator. Am J Cardiol 1990;66:1412-1417
36. Meijer A, Verheught FWA, Werter CJPJ, Lie KI, van der Pol JMJ, van Eenige J. Aspirin versus Coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: a prospective placebo-controlled angiographic study: results of the APRICOT study. Circulation 1993;87:1524-1530